BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35101425)

  • 21. Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia.
    Jacobs F; Van Craeyveld E; Feng Y; Snoeys J; De Geest B
    Atherosclerosis; 2008 Dec; 201(2):289-97. PubMed ID: 18378244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adipose tissue deficiency results in severe hyperlipidemia and atherosclerosis in the low-density lipoprotein receptor knockout mice.
    Wang M; Gao M; Liao J; Qi Y; Du X; Wang Y; Li L; Liu G; Yang H
    Biochim Biophys Acta; 2016 May; 1861(5):410-8. PubMed ID: 26921684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of atherosclerosis by low-fat, semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement).
    Teupser D; Persky AD; Breslow JL
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1907-13. PubMed ID: 12907460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deficiency of LRP1 in Mature Adipocytes Promotes Diet-Induced Inflammation and Atherosclerosis-Brief Report.
    Konaniah ES; Kuhel DG; Basford JE; Weintraub NL; Hui DY
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1046-1049. PubMed ID: 28473440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinatal Hypercholesterolemia Exacerbates Atherosclerosis Lesions in Offspring by Altering Metabolism of Trimethylamine-N-Oxide and Bile Acids.
    Trenteseaux C; Gaston AT; Aguesse A; Poupeau G; de Coppet P; Andriantsitohaina R; Laschet J; Amarger V; Krempf M; Nobecourt-Dupuy E; Ouguerram K
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2053-2063. PubMed ID: 28935756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism.
    Zhou X; He W; Huang Z; Gotto AM; Hajjar DP; Han J
    J Biol Chem; 2008 Jan; 283(4):2129-38. PubMed ID: 18029360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ablation of Plasma Prekallikrein Decreases Low-Density Lipoprotein Cholesterol by Stabilizing Low-Density Lipoprotein Receptor and Protects Against Atherosclerosis.
    Wang JK; Li Y; Zhao XL; Liu YB; Tan J; Xing YY; Adi D; Wang YT; Fu ZY; Ma YT; Liu SM; Liu Y; Wang Y; Shi XJ; Lu XY; Song BL; Luo J
    Circulation; 2022 Mar; 145(9):675-687. PubMed ID: 35189703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficiency of receptor-associated protein attenuates angiotensin II-induced atherosclerosis in hypercholesterolemic mice without influencing abdominal aortic aneurysms.
    Wang S; Subramanian V; Lu H; Howatt DA; Moorleghen JJ; Charnigo R; Cassis LA; Daugherty A
    Atherosclerosis; 2012 Feb; 220(2):375-80. PubMed ID: 22153700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice.
    Kirk EA; Sutherland P; Wang SA; Chait A; LeBoeuf RC
    J Nutr; 1998 Jun; 128(6):954-9. PubMed ID: 9614153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxes.
    Stöger JL; Boshuizen MC; Brufau G; Gijbels MJ; Wolfs IM; van der Velden S; Pöttgens CC; Vergouwe MN; Wijnands E; Beckers L; Goossens P; Kerksiek A; Havinga R; Müller W; Lütjohann D; Groen AK; de Winther MP
    Thromb Haemost; 2016 Aug; 116(3):565-77. PubMed ID: 27358035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lectin-like oxidized low-density lipoprotein receptor-1 promotes endothelial dysfunction in LDL receptor knockout background.
    Hofmann A; Brunssen C; Poitz DM; Langbein H; Strasser RH; Henle T; Ravens U; Morawietz H
    Atheroscler Suppl; 2017 Nov; 30():294-302. PubMed ID: 29096854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia.
    O'Hare EA; Wang X; Montasser ME; Chang YP; Mitchell BD; Zaghloul NA
    J Lipid Res; 2014 Nov; 55(11):2242-53. PubMed ID: 25201834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial Effects of Moderate Hepatic Activin A Expression on Metabolic Pathways, Inflammation, and Atherosclerosis.
    Liu H; Hallauer Hastings M; Kitchen R; Xiao C; Baldovino Guerra JR; Kuznetsov A; Rosenzweig A
    Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):330-349. PubMed ID: 36453275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver-selective γ-secretase inhibition ameliorates diet-induced hepatic steatosis, dyslipidemia and atherosclerosis.
    Kim K; Yu J; Kang JK; Morrow JP; Pajvani UB
    Biochem Biophys Res Commun; 2020 Jul; 527(4):979-984. PubMed ID: 32439159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary Supplementation with Galactooligosaccharides Attenuates High-Fat, High-Cholesterol Diet-Induced Glucose Intolerance and Disruption of Colonic Mucin Layer in C57BL/6 Mice and Reduces Atherosclerosis in Ldlr-/- Mice.
    Ghosh SS; Wang J; Yannie PJ; Sandhu YK; Korzun WJ; Ghosh S
    J Nutr; 2020 Feb; 150(2):285-293. PubMed ID: 31586202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr
    Rajamoorthi A; Lee RG; Baldán Á
    Atherosclerosis; 2018 Aug; 275():43-49. PubMed ID: 29859472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice.
    Out R; Hoekstra M; Hildebrand RB; Kruit JK; Meurs I; Li Z; Kuipers F; Van Berkel TJ; Van Eck M
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2295-300. PubMed ID: 16857950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
    Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPARγ (Peroxisome Proliferator-Activated Receptor γ) Deacetylation Suppresses Aging-Associated Atherosclerosis and Hypercholesterolemia.
    Zahr T; Liu L; Chan M; Zhou Q; Cai B; He Y; Aaron N; Accili D; Sun L; Qiang L
    Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):30-44. PubMed ID: 36453279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr
    Zhao L; Cozzo AJ; Johnson AR; Christensen T; Freemerman AJ; Bear JE; Rotty JD; Bennett BJ; Makowski L
    Atherosclerosis; 2017 Nov; 266():182-189. PubMed ID: 29035781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.